MD Anderson study: Adolescent, young adult leukemia survivors have shorter life span than those who have never had cancer

MD Anderson and industry partners to conduct T cell studies on the International Space Station

The University of Texas MD Anderson Cancer Center and collaborators are initiating a research project that will send T cells to the International Space Station to study the effects of prolonged microgravity on cell differentiation, activation, memory, and exhaustion.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Calquence combination significantly improved PFS in CLL in phase III trial

Positive high-level results from an interim analysis of the AMPLIFY phase III trial showed a fixed duration of Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard-of-care chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukemia.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Modifying, deleting, or degrading protein ZFP574 reduces division of malignant B cells in lab

Targeting a protein called ZFP574 suppressed leukemia in a mouse model of the disease, UT Southwestern Medical Center researchers showed in a new study. Their findings, published in PNAS, could lead to new treatments for leukemias and lymphomas in cancer patients.

August 02, 2024

Vol.50 No.31

In Brief

MD Anderson, Rice form Cancer Bioengineering Collaborative

The University of Texas MD Anderson Cancer Center and Rice University formed the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis, and treatment.

June 28, 2024

Vol.50 No.26

Clinical Roundup

Upregulating TERT gene expression reverses multiple hallmarks of aging

Researchers at MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models.

June 28, 2024

Vol.50 No.26

In Brief

MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council

The Institute for Data Science in Oncology at MD Anderson Cancer Center has established an internal advisory council to identify needs and opportunities for data science development and integration across MD Anderson, advancing work that will yield significant benefits for patients and families.

June 21, 2024

Vol.50 No.25

MD Anderson study: Adolescent, young adult leukemia survivors have shorter life span than those who have never had cancer

YOU MAY BE INTERESTED IN

MD Anderson and industry partners to conduct T cell studies on the International Space Station

Calquence combination significantly improved PFS in CLL in phase III trial

Modifying, deleting, or degrading protein ZFP574 reduces division of malignant B cells in lab

MD Anderson, Rice form Cancer Bioengineering Collaborative

Upregulating TERT gene expression reverses multiple hallmarks of aging

MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council

Renew today!

Subscriber content

Login